The purpose of this study is to determine how quality of life changes after surgical removal of wisdom teeth

A significant percentage of patients are subjected to surgical removal of 3. molars every year. The surgical mucosal and osseous procedure may lead to postoperative discomfort including pain, for the patient. Information with respect to how patients regard the impact of this surgical treatment on oral health including pain and swelling is of great interest. More precise information about the postoperative course following this surgery will be beneficial in improving clinical treatment procedures with respect to alleviating the patients' postoperative period.

Inclusion Criteria:

• Patients of either sex of Caucasian origin, between the age of 18 and 45, who are candidates for surgical removal of one mandibular 3. molar

Exclusion Criteria:

• Chronic drug treatment (except birth control medication) with analgesics, anti-inflammatory treatment (both steroidal (SAIDs) and non-steroidal anti-inflammatory drugs (NSAIDs)) apart from standard postoperative analgesic treatment administered by the operator.
• The necessity for anti-microbial drugs.
• Pregnant or lactating women.
• Patients with diabetes.
• Patients who due to age or communication skills are considered unable to complete patient forms.
• Professional evaluation suggests an alteration of the planned surgical area or treatment form.
• Surgery exceeding 45 minutes, from time of first incision to completed suturing.
• Known or assumed intolerance or hypersensibility to ibuprofen (standard postoperative analgesic treatment).
• Known or assumed intolerance or hypersensibility to the standard local anaesthetic Xylocain-adrenalin (lidocaine-adrenalin).
• Consumption of alcohol in the period from 2 days before or until the end of the primary observation period (postoperative days 0-7.

Norwegian outpatients patients of Caucasian origin operated in a primary care clinic